Canakinumab vs Pembrolizumab

## Canakinumab vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Canakinumab** and **Pembrolizumab**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Canakinumab — N/A; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Canakinumab — Antibody; Pembrolizumab — Antibody.